Angiosarcoma follow-up 2 validation study
A bespoke targeted pulldown experiment will be performed on patients with Angiosarcoma. the resulting products will be sequenced to determine the prevalence of previously found mutations in these patients.
- Technology: Illumina HiSeq 2000
- 107 samples
- DAC: EGAC00001000010
Studies are experimental investigations of a particular phenomenon. e.g. case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients. Click on one of the Study IDs below to find out more.
|Study ID||Study Title||Study Type|